Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

VivoPower Appoints Group Finance Director

VivoPower Appoints Group Finance Director

VivoPower PLC has appointed Syed Muhammad Nouman as Group Finance Director, effective July 20, 2026. Nouman brings over 17 years of global finance leadership experience and will serve as the Principal Financial Officer and Principal Accounting Officer. His appointment aims to reinforce VivoPower's finance functions to support scaling of its soverei…

Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer

Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer

Oncolytics Biotech Inc. announced that the FDA has granted Fast Track designation to its investigational immunotherapy pelareorep for treating patients with advanced squamous cell carcinoma of the anal canal who have progressed after prior therapies. This marks the third Fast Track designation in gastrointestinal cancers for pelareorep, reinforcing…

TMC Welcomes Unanimous Decisions by International Tribunal for the Law of the Sea Ordering the ISA to Respect NORI and TOML’s Due Process Rights

TMC Welcomes Unanimous Decisions by International Tribunal for the Law of the Sea Ordering the ISA to Respect NORI and TOML’s Due Process Rights

The Metals Company announced that the International Tribunal for the Law of the Sea issued unanimous orders protecting the due process rights of its subsidiaries, NORI and TOML, in their legal proceedings against the International Seabed Authority (ISA). The tribunal mandates the ISA to respect the legal framework and due process in contract consid…

Baosheng Signed Non-Binding MOU with Zhongcheng Kexin to jointly build an AI full‑scenario marketing and service platform for scenic areas

Baosheng Signed Non-Binding MOU with Zhongcheng Kexin to jointly build an AI full‑scenario marketing and service platform for scenic areas

Baosheng Media Group Holdings Limited (NASDAQ: BAOS) has entered into a non-binding MOU with Beijing Zhongcheng Kexin Technology Development Co., Ltd. to explore a strategic collaboration in the cultural tourism sector. The collaboration aims to integrate Baosheng's AI short-form video marketing capabilities with Zhongcheng Kexin's smart scenic-are…

K Wave Media Announces Nasdaq Capital Market Approval, Strengthened Balance Sheet and Strategic AI Growth Initiative

K Wave Media Announces Nasdaq Capital Market Approval, Strengthened Balance Sheet and Strategic AI Growth Initiative

K Wave Media Ltd. announced Nasdaq approval to move its listing from the Nasdaq Global Market to the Nasdaq Capital Market, gaining an extended compliance period to meet bid price requirements. The company completed significant financial restructuring, improving shareholders' equity from a deficit to approximately $22 million and reducing liabiliti…

Rocky Mountain Chocolate Factory Expands Company-Owned Store Portfolio with Acquisition of Chino Hills, California Location

Rocky Mountain Chocolate Factory Expands Company-Owned Store Portfolio with Acquisition of Chino Hills, California Location

Rocky Mountain Chocolate Factory has acquired its franchised store in Chino Hills, California, converting it into a company-owned location. This strategic acquisition expands their company-owned stores to five, providing a platform for operational innovation, new merchandising, and digital initiatives to enhance customer experience and support fran…

BondBloxx Midyear Outlook: Record Bond ETF Inflows in First Half of 2026 and the Case for Fixed Income as Stock Valuations Stretch

BondBloxx Midyear Outlook: Record Bond ETF Inflows in First Half of 2026 and the Case for Fixed Income as Stock Valuations Stretch

BondBloxx Investment Management highlights a surge in fixed income ETF inflows exceeding $300 billion in the first half of 2026, surpassing previous records. The company emphasizes fixed income's renewed role in income generation and market stability as equity market valuations become stretched and volatile. BondBloxx offers targeted bond ETF strat…

ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026

ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026

ORIC Pharmaceuticals announced three poster presentations at the ESMO Congress 2026 showcasing data on its clinical stage oncology drugs enozertinib and rinzimetostat. These presentations include early-phase trial results of enozertinib for first-line treatment of atypical EGFR mutated NSCLC and ongoing Phase 3 trial design and preclinical mechanis…

XFLT Outlines Numerous Benefits of the King Street Sub-Adviser Proposal to Shareholders Ahead of Upcoming Proxy Vote

XFLT Outlines Numerous Benefits of the King Street Sub-Adviser Proposal to Shareholders Ahead of Upcoming Proxy Vote

XAI Floating Rate & Alternative Income Trust (XFLT) is urging shareholders to approve a new sub-advisory agreement with King Street Capital Management subsidiary ahead of a July 30, 2026 special meeting. The proposal highlights potential benefits such as increased distributions, improved long-term performance, expanded investment opportunities in U…

Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026

Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026

Dogwood Therapeutics announced the enrollment of the first 200 patients in its ongoing Phase 2b trial for Halneuron®, a non-opioid treatment for chemotherapy-induced neuropathic pain (CINP). An independent committee noted early pain improvement signals in treated patients versus placebo. The trial remains on track for results in Fall 2026. The comp…

ParaZero Successfully Demonstrates its Counter-UAS System in France

ParaZero Successfully Demonstrates its Counter-UAS System in France

ParaZero Technologies Ltd., listed on Nasdaq under the ticker PRZO, successfully demonstrated its DefendAir counter-unmanned aerial system (UAS) interception platform in France. The DefendAir system, designed for real-world operational scenarios, uses a non-explosive net-based method to neutralize hostile drones, addressing the rising demand for ef…

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

Enlivex Ltd. announced an update on its treasury portfolio, highlighting a net asset value (NAV) per ordinary share of $66.16 as of July 18, 2026, and holding approximately 79.6 billion RAIN tokens valued at $1.1 billion. The company combines longevity therapeutics development with a digital assets treasury based on the RAIN token and prediction ma…

BigCommerce Powered by Commerce Scores 24/24 Total Medals in 2026 Paradigm B2B Combine Midmarket and Enterprise Editions for Fourth Consecutive Year

BigCommerce Powered by Commerce Scores 24/24 Total Medals in 2026 Paradigm B2B Combine Midmarket and Enterprise Editions for Fourth Consecutive Year

Commerce's ecommerce platform BigCommerce earned all 24 medals in the 2026 Paradigm B2B Combines across Midmarket and Enterprise editions for the fourth consecutive year. The platform won multiple gold and silver medals, highlighting its strength in operational efficiency, complex pricing capabilities, partner ecosystem, and AI-driven innovations. …

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026

Phathom Pharmaceuticals, a biopharmaceutical company focused on gastrointestinal treatments, will report its Q2 2026 financial results and provide a business update via webcast on July 30, 2026. The company markets vonoprazan-based therapies for GERD and H. pylori infections in the U.S. and holds rights in major markets including the U.S., Europe, …

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

Eikon Therapeutics announced acceptance of seven abstracts for presentation at the 2026 European Society of Medical Oncology (ESMO) Congress. These presentations include updates on multiple clinical trials evaluating their novel oncology drug candidates, including TLR7/8 dual agonist EIK1001 for advanced NSCLC, selective PARP1 inhibitors EIK1003 an…

Byrna Technologies Appoints Proven Retail and Omnichannel Sales Leader James White as Senior Vice President of Retail & Channel Growth

Byrna Technologies Appoints Proven Retail and Omnichannel Sales Leader James White as Senior Vice President of Retail & Channel Growth

Byrna Technologies Inc., a Nasdaq-listed personal defense technology company, announced the appointment of James White as Senior Vice President of Retail & Channel Growth. White brings over 25 years of experience in retail and omnichannel sales leadership and will oversee Byrna's retail and e-commerce channels to accelerate growth. The appointment …